migraine

News

A sad young woman is sitting in her kitchen with a headache

Lilly joins CGRP race to cure migraine

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a

News

Novartis/Amgen's migraine drug hits market at lower than exp...

The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and at a lower than expected list price of $6,900.

News

Lilly drug scrapes through cluster headache trial

FDA to make decision on Amgen drug tomorrow

News

Lilly and Alder showcase latest migraine drug data

Lilly and Alder take on the might of Novartis and Amgen

News

Novartis/Amgen migraine jab works in tough-to-treat patients

Novartis continues to build the case for its Aimovig migraine injection,with data showing it works in a tough-to-treat patient group.

News

Sosei see Teva pipeline cull as an opportunity

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.

Lilly joins CGRP race to cure migraine

Novartis/Amgen's migraine drug hits market at lower than exp...

Lilly drug scrapes through cluster headache trial

Lilly and Alder showcase latest migraine drug data

Novartis/Amgen migraine jab works in tough-to-treat patients

Sosei see Teva pipeline cull as an opportunity

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

migraine

Editor's Picks